Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Diversified Healthcare Trust (NASDAQ: DHC) closed the day trading at $2.42 down -1.63% from the previous closing price of $2.46. In other words, the price has decreased by -$1.63 from its previous closing price. On the day, 0.89 million shares were traded. DHC stock price reached its highest trading level at $2.465 during the session, while it also had its lowest trading level at $2.345.
Ratios:
For a better understanding of DHC, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.50 whereas as Long-Term Debt/Eq ratio is at 1.30.
Wells Fargo Downgraded its Overweight to Equal Weight on January 17, 2020, while the target price for the stock was maintained at $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 13 ’24 when Brown Matthew C. bought 2,000 shares for $2.55 per share. The transaction valued at 5,098 led to the insider holds 86,282 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DHC now has a Market Capitalization of 583791168 and an Enterprise Value of 3370608640. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 0.30. Its current Enterprise Value per Revenue stands at 2.254 whereas that against EBITDA is 14.657.
Stock Price History:
The Beta on a monthly basis for DHC is 2.01, which has changed by 0.004149437 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, DHC has reached a high of $4.24, while it has fallen to a 52-week low of $2.01. The 50-Day Moving Average of the stock is -3.32%, while the 200-Day Moving Average is calculated to be -17.59%.
Shares Statistics:
Over the past 3-months, DHC traded about 1.04M shares per day on average, while over the past 10 days, DHC traded about 995360 shares per day. A total of 241.27M shares are outstanding, with a floating share count of 216.59M. Insiders hold about 10.22% of the company’s shares, while institutions hold 75.60% stake in the company. Shares short for DHC as of 1741910400 were 8776509 with a Short Ratio of 8.37, compared to 1739491200 on 7493147. Therefore, it implies a Short% of Shares Outstanding of 8776509 and a Short% of Float of 7.0700005.
Dividends & Splits
DHC’s forward annual dividend rate is 0.04, up from 0.04 a year ago. Against a Trailing Annual Dividend Yield of 0.016260162The stock’s 5-year Average Dividend Yield is 3.18.
Earnings Estimates
The market rating for Diversified Healthcare Trust (DHC) is a result of the insights provided by 1.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.23 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.92 and -$0.92 for the fiscal current year, implying an average EPS of -$0.92. EPS for the following year is -$0.76, with 1.0 analysts recommending between -$0.76 and -$0.76.
Revenue Estimates
1 analysts predict $385.6M in revenue for the current quarter. It ranges from a high estimate of $385.6M to a low estimate of $385.6M. As of the current estimate, Diversified Healthcare Trust’s year-ago sales were $370.78MFor the next quarter, 1 analysts are estimating revenue of $386.6M. There is a high estimate of $386.6M for the next quarter, whereas the lowest estimate is $386.6M.
A total of 1 analysts have provided revenue estimates for DHC’s current fiscal year. The highest revenue estimate was $1.63B, while the lowest revenue estimate was $1.63B, resulting in an average revenue estimate of $1.63B. In the same quarter a year ago, actual revenue was $1.5BBased on 2 analysts’ estimates, the company’s revenue will be $1.68B in the next fiscal year. The high estimate is $1.83B and the low estimate is $1.53B.
